Chembond Chemicals Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 9, 2025, 8:09 pm

Market Cap	792 Cr.
Current Price	589
High / Low	746/436
Stock P/E	20.2
Book Value	282
Dividend Yield	0.59 %
ROCE	15.6 %
ROE	11.6 %
Face Value	5.00
PEG Ratio	1.38

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Chembond Chemicals Ltd

Competitors of Chembond Chemicals Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
HP Adhesives Ltd	431 Cr.	47.0	115/42.6	22.3	19.2	0.64 %	17.7 %	12.6 %	2.00
Haryana Leather Chemicals Ltd	38.3 Cr.	78.0	124/56.8	9.30	87.2	1.28 %	8.96 %	7.25 %	10.0
Hardcastle & Waud Mfg Co Ltd	48.3 Cr.	710	1,355/563	27.6	663	0.00 %	7.00 %	5.98 %	10.0
Grauer & Weil (India) Ltd	4,145 Cr.	91.4	120/72.2	25.8	19.2	0.55 %	26.1 %	19.6 %	1.00
DMCC Speciality Chemicals Ltd	765 Cr.	298	453/245	36.7	85.4	0.34 %	7.55 %	2.89 %	10.0
Industry Average	9,517.86	N/A		40.12	N/A	N/A	13.99	10.39	N/A

All Competitor Stocks of Chembond Chemicals Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	93	94	98	110	111	122	114	112	115	122	109	124	126
Expenses	89	91	97	101	99	109	105	98	100	110	100	111	108
Operating Profit	5	3	1	9	11	13	9	15	14	12	9	13	18
OPM %	5%	3%	1%	8%	10%	11%	8%	13%	12%	10%	8%	10%	14%
Other Income	1	1	0	1	1	2	3	9	4	1	4	7	0
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	1	1	1	1	1	1	1	1	1	2	2	2	2
Profit before tax	4	3	0	9	11	13	11	22	16	11	11	17	16
Tax %	40%	24%	770%	14%	27%	22%	17%	30%	16%	41%	28%	20%	27%
Net Profit	2	2	-1	8	8	10	9	15	13	7	8	14	12
EPS in Rs	1.75	1.55	-1.02	5.75	6.14	7.58	6.51	11.48	10.04	4.99	5.93	10.31	8.71

Last Updated: March 3, 2025, 5:01 pm

Below is a detailed analysis of the quarterly data for Chembond Chemicals Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹126.00 Cr.. The value appears strong and on an upward trend. It has increased from 124.00 Cr. (Sep 2024) to ₹126.00 Cr., marking an increase of ₹2.00 Cr..
For Expenses, as of Dec 2024, the value is ₹108.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 111.00 Cr. (Sep 2024) to ₹108.00 Cr., marking a decrease of 3.00 Cr..
For Operating Profit, as of Dec 2024, the value is ₹18.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Sep 2024) to ₹18.00 Cr., marking an increase of ₹5.00 Cr..
For OPM %, as of Dec 2024, the value is 14.00%. The value appears strong and on an upward trend. It has increased from 10.00% (Sep 2024) to 14.00%, marking an increase of 4.00%.
For Other Income, as of Dec 2024, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Sep 2024) to ₹0.00 Cr., marking a decrease of 7.00 Cr..
For Interest, as of Dec 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
For Depreciation, as of Dec 2024, the value is ₹2.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 2.00 Cr..
For Profit before tax, as of Dec 2024, the value is ₹16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 17.00 Cr. (Sep 2024) to ₹16.00 Cr., marking a decrease of 1.00 Cr..
For Tax %, as of Dec 2024, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 20.00% (Sep 2024) to 27.00%, marking an increase of 7.00%.
For Net Profit, as of Dec 2024, the value is ₹12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14.00 Cr. (Sep 2024) to ₹12.00 Cr., marking a decrease of 2.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 8.71. The value appears to be declining and may need further review. It has decreased from ₹10.31 (Sep 2024) to 8.71, marking a decrease of ₹1.60.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 4:35 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	262	274	299	270	291	327	301	268	274	349	440	462	480
Expenses	243	253	273	259	274	304	275	258	256	332	405	412	429
Operating Profit	18	21	26	11	17	23	26	10	18	17	35	49	51
OPM %	7%	8%	9%	4%	6%	7%	8%	4%	7%	5%	8%	11%	11%
Other Income	5	1	1	189	18	11	4	3	15	9	5	17	13
Interest	5	4	4	2	1	1	1	1	0	1	1	1	1
Depreciation	3	3	4	4	4	4	4	4	5	4	5	6	7
Profit before tax	16	15	20	195	30	28	24	8	29	21	34	60	56
Tax %	50%	40%	28%	20%	24%	16%	19%	61%	28%	32%	26%	26%
Net Profit	8	9	14	156	23	24	20	3	20	14	25	44	40
EPS in Rs	5.47	5.80	9.31	114.66	14.37	16.34	12.88	1.39	15.12	10.35	18.66	33.02	29.94
Dividend Payout %	26%	26%	16%	4%	11%	11%	16%	144%	15%	48%	16%	11%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	12.50%	55.56%	1014.29%	-85.26%	4.35%	-16.67%	-85.00%	566.67%	-30.00%	78.57%	76.00%
Change in YoY Net Profit Growth (%)	0.00%	43.06%	958.73%	-1099.54%	89.60%	-21.01%	-68.33%	651.67%	-596.67%	108.57%	-2.57%

Chembond Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	5%
5 Years:	9%
3 Years:	19%
TTM:	4%

Compounded Profit Growth
10 Years:	18%
5 Years:	18%
3 Years:	25%
TTM:	-18%

Stock Price CAGR
10 Years:	13%
5 Years:	25%
3 Years:	46%
1 Year:	20%

Return on Equity
10 Years:	8%
5 Years:	7%
3 Years:	8%
Last Year:	12%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:31 am

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	7	7	7	7	7	7	7	7	7	7	7	7	7
Reserves	75	80	89	200	223	242	255	262	286	297	315	355	373
Borrowings	29	33	25	11	9	9	7	3	2	2	7	7	9
Other Liabilities	71	86	83	72	82	68	54	50	59	56	74	79	77
Total Liabilities	182	205	203	289	321	325	322	322	354	361	402	447	466
Fixed Assets	47	54	51	47	49	108	109	124	122	121	116	122	128
CWIP	5	3	3	2	2	1	2	0	0	1	12	13	7
Investments	1	1	1	88	150	76	58	51	73	75	65	92	104
Other Assets	130	148	147	152	120	140	153	147	160	165	208	220	226
Total Assets	182	205	203	289	321	325	322	322	354	361	402	447	466

Below is a detailed analysis of the balance sheet data for Chembond Chemicals Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹7.00 Cr..
For Reserves, as of Sep 2024, the value is ₹373.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹355.00 Cr. (Mar 2024) to ₹373.00 Cr., marking an increase of 18.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹9.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹7.00 Cr. (Mar 2024) to ₹9.00 Cr., marking an increase of 2.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹77.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹79.00 Cr. (Mar 2024) to ₹77.00 Cr., marking a decrease of 2.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹466.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹447.00 Cr. (Mar 2024) to ₹466.00 Cr., marking an increase of 19.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹128.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹122.00 Cr. (Mar 2024) to ₹128.00 Cr., marking an increase of 6.00 Cr..
For CWIP, as of Sep 2024, the value is ₹7.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹13.00 Cr. (Mar 2024) to ₹7.00 Cr., marking a decrease of 6.00 Cr..
For Investments, as of Sep 2024, the value is ₹104.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹92.00 Cr. (Mar 2024) to ₹104.00 Cr., marking an increase of 12.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹226.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹220.00 Cr. (Mar 2024) to ₹226.00 Cr., marking an increase of 6.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹466.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹447.00 Cr. (Mar 2024) to ₹466.00 Cr., marking an increase of 19.00 Cr..

Notably, the Reserves (₹373.00 Cr.) exceed the Borrowings (9.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	7	10	24	-27	5	-12	-12	24	25	-10	1	28
Cash from Investing Activity +	-7	-6	-3	52	-0	19	14	-12	-11	-2	1	-22
Cash from Financing Activity +	-8	-4	-18	-24	-3	-4	-6	-11	-2	-4	-2	-5
Net Cash Flow	-8	-0	3	1	2	3	-5	1	12	-16	0	1

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-11.00	-12.00	1.00	0.00	8.00	14.00	19.00	7.00	16.00	15.00	28.00	42.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	100	116	105	78	84	90	110	112	111	94	96	95
Inventory Days	69	74	60	46	59	46	58	77	82	67	53	54
Days Payable	95	113	96	86	95	96	84	96	120	76	81	88
Cash Conversion Cycle	74	77	70	38	49	40	84	94	73	84	67	62
Working Capital Days	75	81	69	104	53	53	89	102	85	79	75	70
ROCE %	17%	15%	18%	22%	12%	11%	9%	3%	10%	7%	10%	16%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	66.28%	66.28%	67.49%	67.55%	67.55%	67.54%	67.54%	67.55%	67.55%	67.56%	67.61%	67.63%
FIIs	0.69%	0.57%	0.57%	0.57%	0.58%	0.57%	0.59%	1.10%	0.94%	0.66%	0.69%	0.81%
DIIs	0.83%	0.83%	0.83%	0.83%	0.69%	0.69%	0.69%	0.98%	1.18%	1.21%	1.18%	1.26%
Public	32.20%	32.32%	31.10%	31.05%	31.18%	31.20%	31.18%	30.36%	30.32%	30.56%	30.52%	30.30%
No. of Shareholders	10,440	10,558	11,086	10,036	9,483	9,458	9,480	9,818	10,145	10,840	12,429	13,407

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	5.00	5.00	5.00	5.00	5.00
Basic EPS (Rs.)	33.02	18.36	10.35	15.13	1.39
Diluted EPS (Rs.)	33.02	18.36	10.35	15.13	1.39
Cash EPS (Rs.)	37.08	21.77	13.73	18.56	5.53
Book Value[Excl.RevalReserv]/Share (Rs.)	269.75	240.37	226.99	218.95	203.69
Book Value[Incl.RevalReserv]/Share (Rs.)	269.75	240.37	226.99	218.95	203.69
Revenue From Operations / Share (Rs.)	343.53	327.51	259.82	204.08	199.32
PBDIT / Share (Rs.)	49.51	29.16	19.11	24.91	9.68
PBIT / Share (Rs.)	45.39	25.81	15.78	21.53	6.45
PBT / Share (Rs.)	44.51	25.04	15.27	21.21	5.87
Net Profit / Share (Rs.)	32.95	18.42	10.40	15.18	2.29
NP After MI And SOA / Share (Rs.)	33.02	18.41	10.35	15.13	1.39
PBDIT Margin (%)	14.41	8.90	7.35	12.20	4.85
PBIT Margin (%)	13.21	7.88	6.07	10.54	3.23
PBT Margin (%)	12.95	7.64	5.87	10.39	2.94
Net Profit Margin (%)	9.59	5.62	4.00	7.43	1.15
NP After MI And SOA Margin (%)	9.61	5.62	3.98	7.41	0.69
Return on Networth / Equity (%)	12.28	7.69	4.57	6.93	0.69
Return on Capital Employeed (%)	16.71	10.68	6.91	9.76	3.14
Return On Assets (%)	9.93	6.16	3.85	5.74	0.58
Total Debt / Equity (X)	0.01	0.02	0.00	0.01	0.01
Asset Turnover Ratio (%)	1.09	0.16	0.15	0.14	0.20
Current Ratio (X)	3.07	2.73	3.59	3.17	3.50
Quick Ratio (X)	2.67	2.29	2.96	2.66	2.91
Inventory Turnover Ratio (X)	6.11	0.96	1.13	1.04	1.92
Dividend Payout Ratio (NP) (%)	9.08	27.15	0.00	0.00	287.21
Dividend Payout Ratio (CP) (%)	8.07	22.97	0.00	0.00	86.47
Earning Retention Ratio (%)	90.92	72.85	0.00	0.00	-187.21
Cash Earning Retention Ratio (%)	91.93	77.03	0.00	0.00	13.53
Interest Coverage Ratio (X)	56.59	37.66	37.30	79.42	16.63
Interest Coverage Ratio (Post Tax) (X)	38.66	24.79	21.30	49.37	4.94
Enterprise Value (Cr.)	612.05	328.75	224.11	233.11	193.26
EV / Net Operating Revenue (X)	1.32	0.74	0.64	0.84	0.72
EV / EBITDA (X)	9.19	8.38	8.72	6.96	14.84
MarketCap / Net Operating Revenue (X)	1.39	0.77	0.68	0.93	0.73
Retention Ratios (%)	90.91	72.84	0.00	0.00	-187.21
Price / BV (X)	1.78	1.06	0.79	0.87	0.73
Price / Net Operating Revenue (X)	1.39	0.77	0.68	0.93	0.73
EarningsYield	0.06	0.07	0.05	0.07	0.01

After reviewing the key financial ratios for Chembond Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 5.00.
For Basic EPS (Rs.), as of Mar 24, the value is 33.02. This value is within the healthy range. It has increased from 18.36 (Mar 23) to 33.02, marking an increase of 14.66.
For Diluted EPS (Rs.), as of Mar 24, the value is 33.02. This value is within the healthy range. It has increased from 18.36 (Mar 23) to 33.02, marking an increase of 14.66.
For Cash EPS (Rs.), as of Mar 24, the value is 37.08. This value is within the healthy range. It has increased from 21.77 (Mar 23) to 37.08, marking an increase of 15.31.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 269.75. It has increased from 240.37 (Mar 23) to 269.75, marking an increase of 29.38.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 269.75. It has increased from 240.37 (Mar 23) to 269.75, marking an increase of 29.38.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 343.53. It has increased from 327.51 (Mar 23) to 343.53, marking an increase of 16.02.
For PBDIT / Share (Rs.), as of Mar 24, the value is 49.51. This value is within the healthy range. It has increased from 29.16 (Mar 23) to 49.51, marking an increase of 20.35.
For PBIT / Share (Rs.), as of Mar 24, the value is 45.39. This value is within the healthy range. It has increased from 25.81 (Mar 23) to 45.39, marking an increase of 19.58.
For PBT / Share (Rs.), as of Mar 24, the value is 44.51. This value is within the healthy range. It has increased from 25.04 (Mar 23) to 44.51, marking an increase of 19.47.
For Net Profit / Share (Rs.), as of Mar 24, the value is 32.95. This value is within the healthy range. It has increased from 18.42 (Mar 23) to 32.95, marking an increase of 14.53.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 33.02. This value is within the healthy range. It has increased from 18.41 (Mar 23) to 33.02, marking an increase of 14.61.
For PBDIT Margin (%), as of Mar 24, the value is 14.41. This value is within the healthy range. It has increased from 8.90 (Mar 23) to 14.41, marking an increase of 5.51.
For PBIT Margin (%), as of Mar 24, the value is 13.21. This value is within the healthy range. It has increased from 7.88 (Mar 23) to 13.21, marking an increase of 5.33.
For PBT Margin (%), as of Mar 24, the value is 12.95. This value is within the healthy range. It has increased from 7.64 (Mar 23) to 12.95, marking an increase of 5.31.
For Net Profit Margin (%), as of Mar 24, the value is 9.59. This value is within the healthy range. It has increased from 5.62 (Mar 23) to 9.59, marking an increase of 3.97.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.61. This value is within the healthy range. It has increased from 5.62 (Mar 23) to 9.61, marking an increase of 3.99.
For Return on Networth / Equity (%), as of Mar 24, the value is 12.28. This value is below the healthy minimum of 15. It has increased from 7.69 (Mar 23) to 12.28, marking an increase of 4.59.
For Return on Capital Employeed (%), as of Mar 24, the value is 16.71. This value is within the healthy range. It has increased from 10.68 (Mar 23) to 16.71, marking an increase of 6.03.
For Return On Assets (%), as of Mar 24, the value is 9.93. This value is within the healthy range. It has increased from 6.16 (Mar 23) to 9.93, marking an increase of 3.77.
For Total Debt / Equity (X), as of Mar 24, the value is 0.01. This value is within the healthy range. It has decreased from 0.02 (Mar 23) to 0.01, marking a decrease of 0.01.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.09. It has increased from 0.16 (Mar 23) to 1.09, marking an increase of 0.93.
For Current Ratio (X), as of Mar 24, the value is 3.07. This value exceeds the healthy maximum of 3. It has increased from 2.73 (Mar 23) to 3.07, marking an increase of 0.34.
For Quick Ratio (X), as of Mar 24, the value is 2.67. This value exceeds the healthy maximum of 2. It has increased from 2.29 (Mar 23) to 2.67, marking an increase of 0.38.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 6.11. This value is within the healthy range. It has increased from 0.96 (Mar 23) to 6.11, marking an increase of 5.15.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 9.08. This value is below the healthy minimum of 20. It has decreased from 27.15 (Mar 23) to 9.08, marking a decrease of 18.07.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 8.07. This value is below the healthy minimum of 20. It has decreased from 22.97 (Mar 23) to 8.07, marking a decrease of 14.90.
For Earning Retention Ratio (%), as of Mar 24, the value is 90.92. This value exceeds the healthy maximum of 70. It has increased from 72.85 (Mar 23) to 90.92, marking an increase of 18.07.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 91.93. This value exceeds the healthy maximum of 70. It has increased from 77.03 (Mar 23) to 91.93, marking an increase of 14.90.
For Interest Coverage Ratio (X), as of Mar 24, the value is 56.59. This value is within the healthy range. It has increased from 37.66 (Mar 23) to 56.59, marking an increase of 18.93.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 38.66. This value is within the healthy range. It has increased from 24.79 (Mar 23) to 38.66, marking an increase of 13.87.
For Enterprise Value (Cr.), as of Mar 24, the value is 612.05. It has increased from 328.75 (Mar 23) to 612.05, marking an increase of 283.30.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.32. This value is within the healthy range. It has increased from 0.74 (Mar 23) to 1.32, marking an increase of 0.58.
For EV / EBITDA (X), as of Mar 24, the value is 9.19. This value is within the healthy range. It has increased from 8.38 (Mar 23) to 9.19, marking an increase of 0.81.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.39. This value is within the healthy range. It has increased from 0.77 (Mar 23) to 1.39, marking an increase of 0.62.
For Retention Ratios (%), as of Mar 24, the value is 90.91. This value exceeds the healthy maximum of 70. It has increased from 72.84 (Mar 23) to 90.91, marking an increase of 18.07.
For Price / BV (X), as of Mar 24, the value is 1.78. This value is within the healthy range. It has increased from 1.06 (Mar 23) to 1.78, marking an increase of 0.72.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.39. This value is within the healthy range. It has increased from 0.77 (Mar 23) to 1.39, marking an increase of 0.62.
For EarningsYield, as of Mar 24, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 23) to 0.06, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Chembond Chemicals Ltd as of March 12, 2025 is: ₹531.74

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Chembond Chemicals Ltd is Overvalued by 9.72% compared to the current share price 589.00

Intrinsic Value of Chembond Chemicals Ltd as of March 12, 2025 is: 609.59

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Chembond Chemicals Ltd is Undervalued by 3.50% compared to the current share price 589.00

Last 5 Year EPS CAGR: 14.64%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (234.77 cr) compared to borrowings (11.77 cr), indicating strong financial stability. The company has shown consistent growth in sales (330.54 cr) and profit (41.23 cr) over the years.	The stock has a low average ROCE of 12.50%, which may not be favorable. The stock has a high average Working Capital Days of 77.92, which may not be favorable. The stock has a high average Cash Conversion Cycle of 67.67, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Chembond Chemicals Ltd:
1. Net Profit Margin: 9.59%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 16.71% (Industry Average ROCE: 13.99%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 12.28% (Industry Average ROE: 10.39%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 38.66
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 2.67
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 20.2 (Industry average Stock P/E: 40.12)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.01
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Chembond Chemicals Ltd. is a Public Limited Listed company incorporated on 22/03/1975 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24100MH1975PLC018235 and registration number is 018235. Currently Company is involved in the business activities of Manufacture of other chemical products. Company's Total Operating Revenue is Rs. 52.60 Cr. and Equity Capital is Rs. 6.72 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Chemicals - Speciality - Others	Chembond Centre, EL71, MIDC Mahape, New Mumbai Maharashtra 400710	info@chembondindia.com http://www.chembondindia.com

Management
Name	Position Held
Mr. Sameer V Shah	Chairman & Managing Director
Mr. Nirmal V Shah	Vice Chairman & Mng.Director
Mr. Ashwin R Nagarwadia	Non Executive Director
Mr. Mahendra K Ghelani	Independent Director
Dr. Prakash D Trivedi	Independent Director
Mrs. Saraswati Sankar	Independent Director
Mr. Sushil U Lakhani	Independent Director
Mr. Jayesh P Shah	Addnl.Independent Director

FAQ

What is the latest intrinsic value of Chembond Chemicals Ltd?

The latest intrinsic value of Chembond Chemicals Ltd as on 11 March 2025 is ₹531.74, which is 9.72% lower than the current market price of 589.00, indicating the stock is overvalued by 9.72%. The intrinsic value of Chembond Chemicals Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹792 Cr. and recorded a high/low of ₹746/436 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹373 Cr and total liabilities of ₹466 Cr.

What is the Market Cap of Chembond Chemicals Ltd?

The Market Cap of Chembond Chemicals Ltd is 792 Cr..

What is the current Stock Price of Chembond Chemicals Ltd as on 11 March 2025?

The current stock price of Chembond Chemicals Ltd as on 11 March 2025 is ₹589.

What is the High / Low of Chembond Chemicals Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Chembond Chemicals Ltd stocks is ₹746/436.

What is the Stock P/E of Chembond Chemicals Ltd?

The Stock P/E of Chembond Chemicals Ltd is 20.2.

What is the Book Value of Chembond Chemicals Ltd?

The Book Value of Chembond Chemicals Ltd is 282.

What is the Dividend Yield of Chembond Chemicals Ltd?

The Dividend Yield of Chembond Chemicals Ltd is 0.59 %.

What is the ROCE of Chembond Chemicals Ltd?

The ROCE of Chembond Chemicals Ltd is 15.6 %.

What is the ROE of Chembond Chemicals Ltd?

The ROE of Chembond Chemicals Ltd is 11.6 %.

What is the Face Value of Chembond Chemicals Ltd?

The Face Value of Chembond Chemicals Ltd is 5.00.